Results 221 to 230 of about 57,654 (328)

Correction to: 114. Long-term Protection Against Herpes Zoster (HZ) by the Adjuvanted Recombinant Zoster Vaccine (RZV): Interim Efficacy, Immuno and Safety Results at Approximately 10 Years after Initial Vaccination [PDF]

, 2023

openalex   +1 more source

Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients. [PDF]

BMC Infect Dis, 2021
Chun JY, Kim K, Lee MK, Kang CK, Koh Y, Shin DY, Hong J, Choe PG, Kim NJ, Yoon SS, Park WB, Kim I, Oh MD.   +12 more
europepmc   +1 more source

Awareness, Knowledge, and Vaccine Acceptability ofHerpes Zosterin Korea: A Multicenter Survey of 607 Patients

, 2015
Nam Kyung Roh, Young Min Park, Hoon Kang, Gwang Seong Choi, Beom Joon Kim, Yang Won Lee, Bark‐Lynn Lew, Woo‐Young Sim   +7 more
openalex   +1 more source

Herpes zoster mRNA vaccine induces superior vaccine immunity over licensed vaccine in mice and rhesus macaques [PDF]

, 2023
Lulu Huang, Tongyi Zhao, Weijun Zhao, Andong Shao, Huajun Zhao, Wenxuan Ma, Yingfei Gong, Xianhuan Zeng, Changzhen Weng, Lingling Bu, Zhenhua Di, Shiyu Sun, Qinsheng Dai, Minhui Sun, Limei Wang, Zhenguang Liu, Leilei Shi, Jiesen Hu, Shentong Fang, Cheng Zhang, Jian Zhang, Guan Wang, Karin Loré, Yong Yang, Ang Lin   +24 more
openalex   +1 more source

Herpes zoster emergence following mRNA COVID‐19 vaccine

, 2021
Edward Eid, Lina Abdullah, Mazen Kurban, Ossama Abbas   +3 more
openalex   +1 more source

Faculty Opinions recommendation of Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study.

, 2015
Don Gilden
openalex   +1 more source

A Cost-effectiveness Analysis of an Adjuvanted Subunit Vaccine for the Prevention of Herpes Zoster and Post-herpetic Neuralgia [PDF]

, 2019
Christopher Carpenter, Annas Aljassem, Jerry Stassinopoulos, Giovanni Pisacreta, David W. Hutton   +4 more
openalex   +1 more source

Herpes zoster after COVID‐19 vaccination—Can the vaccine reactivate latent zoster virus?

, 2021
J. A. Palanivel
openalex   +1 more source

Systematic review and meta-analysis of recombinant herpes zoster vaccine in immunocompromised populations. [PDF]

PLoS One
Marra F, Yip M, Cragg JJ, Vadlamudi NK.
europepmc   +1 more source

Acceptability and perception of the herpes zoster vaccine in the 65 and over population: A French observational study.

Vaccine, 2020
C. Del Signore, Anaelle Hemmendinger, N. Khanafer, J. Thierry, Elisabeth Trépo, G. Martin Gaujard, R. Chapurlat, C. Elias, P. Vanhems   +8 more
semanticscholar   +1 more source